Pairwise, founded in 2017 and headquartered in the United States, is positioned at the forefront of agricultural innovation, leveraging cutting-edge CRISPR technology to revolutionize the food and beverage industry. Their slogan, "Building a healthier world through better fruits and vegetables," reflects their commitment to enhancing plant traits for better yield, architecture, and resilience across various crops.
Utilizing their proprietary Fulcrum™ platform, Pairwise combines advanced CRISPR tools with artificial intelligence and a substantial trait library. This enables them to achieve a 72% success rate in targeted plant edits and conduct more than 11 million transformations. Importantly, their non-GMO methodology ensures products are viable for global markets.
Having raised a significant $90.00M in a Series B round on 03 February 2021, Pairwise draws support from reputable investors, including Temasek Holdings, Aliment Capital, Leaps by Bayer, and Deerfield. The company stands out as a potential leader in sustainable agriculture, offering tangible benefits for farmers, consumers, and the environment.